Found: 1381
Select item for more details and to access through your institution.
Surgical quality data and survival after pancreatic cancer resections: a comparison of results for octogenarians and younger patients.
- Published in:
- Wiener Klinische Wochenschrift, 2014, v. 126, n. 23/24, p. 757, doi. 10.1007/s00508-014-0603-8
- By:
- Publication type:
- Article
Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Cancer Patients.
- Published in:
- Cell Biochemistry & Biophysics, 2015, v. 71, n. 3, p. 1287, doi. 10.1007/s12013-014-0345-2
- By:
- Publication type:
- Article
Initial Experience in Total Laparoscopic Central Pancreatectomy with Pancreatogastrostomy.
- Published in:
- Cell Biochemistry & Biophysics, 2015, v. 71, n. 2, p. 1023, doi. 10.1007/s12013-014-0304-y
- By:
- Publication type:
- Article
Ski Acts as Therapeutic Target of Qingyihuaji Formula in the Treatment of SW1990 Pancreatic Cancer.
- Published in:
- Integrative Cancer Therapies, 2010, v. 9, n. 1, p. 50, doi. 10.1177/1534735409359179
- By:
- Publication type:
- Article
Revisiting the ALA/N (α-Lipoic Acid/Low-Dose Naltrexone) Protocol for People With Metastatic and Nonmetastatic Pancreatic Cancer: A Report of 3 New Cases.
- Published in:
- Integrative Cancer Therapies, 2009, v. 8, n. 4, p. 416, doi. 10.1177/1534735409352082
- By:
- Publication type:
- Article
Cyclic Depsipeptide BE-43547A<sub>2</sub>: Synthesis and Activity against Pancreatic Cancer Stem Cells.
- Published in:
- Angewandte Chemie, 2017, v. 129, n. 46, p. 14819, doi. 10.1002/ange.201709744
- By:
- Publication type:
- Article
A phase II study evaluating bevacizumab in combination with fixed-dose rate gemcitabine and low-dose cisplatin for metastatic pancreatic cancer: is an anti-VEGF strategy still applicable?
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 5, p. 463, doi. 10.1007/s10637-008-9127-2
- By:
- Publication type:
- Article
Optimal control of nausea and vomiting with a three-drug antiemetic regimen with aprepitant in metastatic pancreatic cancer patients treated with first-line modified FOLFIRINOX.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Pancreatic cancer and supportive care-pancreatic exocrine insufficiency negatively impacts on quality of life.
- Published in:
- Supportive Care in Cancer, 2013, v. 21, n. 7, p. 1835, doi. 10.1007/s00520-013-1729-3
- By:
- Publication type:
- Article
Chemotherapy in patients with advanced pancreatic cancer: too close to death?
- Published in:
- Supportive Care in Cancer, 2013, v. 21, n. 1, p. 157, doi. 10.1007/s00520-012-1505-9
- By:
- Publication type:
- Article
Symptoms in advanced pancreatic cancer are of importance for energy intake.
- Published in:
- Supportive Care in Cancer, 2013, v. 21, n. 1, p. 219, doi. 10.1007/s00520-012-1514-8
- By:
- Publication type:
- Article
Pancreatic tumours in children: diagnosis, treatment and outcome.
- Published in:
- Pediatric Surgery International, 2015, v. 31, n. 9, p. 831, doi. 10.1007/s00383-015-3727-7
- By:
- Publication type:
- Article
Correction to: Magnetic resonance with diffusion-weighted imaging improves assessment of focal liver lesions in patients with potentially resectable pancreatic cancer on CT.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Surgery after FOLFIRINOX treatment for locally advanced and borderline resectable pancreatic cancer: increase in tumour attenuation on CT correlates with R0 resection.
- Published in:
- 2018
- By:
- Publication type:
- journal article
In vivo study of enhanced chemotherapy combined with ultrasound image-guided focused ultrasound (USgFUS) treatment for pancreatic cancer in a xenograft mouse model.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Structured reporting of pelvic MRI leads to better treatment planning of uterine leiomyomas.
- Published in:
- 2018
- By:
- Publication type:
- editorial
CT evaluation after neoadjuvant FOLFIRINOX chemotherapy for borderline and locally advanced pancreatic adenocarcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Increased tumour ADC value during chemotherapy predicts improved survival in unresectable pancreatic cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Modified vaccinia Ankara expressing survivin combined with gemcitabine generates specific antitumor effects in a murine pancreatic carcinoma model.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 1, p. 99, doi. 10.1007/s00262-010-0923-0
- By:
- Publication type:
- Article
Pancreatic Cancer 3D Cell Line Organoids (CLOs) Maintain the Phenotypic Characteristics of Organoids and Accurately Reflect the Cellular Architecture and Heterogeneity In Vivo.
- Published in:
- Organoids, 2022, v. 1, n. 2, p. 168, doi. 10.3390/organoids1020013
- By:
- Publication type:
- Article
Potential benefit of treatment with MEK inhibitors and chemotherapy in BRAF-mutated KRAS wild-type pancreatic ductal adenocarcinoma patients: a case report.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Pancreatic cancer: An update on diagnosis and management.
- Published in:
- Australian Journal of General Practice, 2019, v. 48, n. 12, p. 823, doi. 10.31128/ajgp-06-19-4957
- By:
- Publication type:
- Article
Walking the tightrope: Early detection of cancer requires vigilance.
- Published in:
- Australian Journal of General Practice, 2019, v. 48, n. 12, p. 821, doi. 10.31128/ajgp-11-19-1234e
- By:
- Publication type:
- Article
FOLFIRINOX Chemotherapy in Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis of Retrospective and Phase II Studies.
- Published in:
- Journal of Clinical Medicine, 2018, v. 7, n. 1, p. 7, doi. 10.3390/jcm7010007
- By:
- Publication type:
- Article
Current Value of Perioperative Therapies for Resectable or Borderline Resectable Pancreatic Cancer.
- Published in:
- Yonago Acta Medica, 2023, v. 66, n. 2, p. 202, doi. 10.33160/yam.2023.05.014
- By:
- Publication type:
- Article
Evaluation of Blood Supply with Indocyanine Green Fluorescence in Resection for Concurrent Gastric and Pancreatic Cancer: A Case Report.
- Published in:
- Yonago Acta Medica, 2021, v. 64, n. 1, p. 133, doi. 10.33160/yam.2021.02.017
- By:
- Publication type:
- Article
Palliative care of the patient with metastatic pancreatic cancer.
- Published in:
- Paliatia: Journal of Palliative Care, 2017, v. 10, n. 3, p. 4
- By:
- Publication type:
- Article
Editorial Board / Contents / Imprint.
- Published in:
- 2018
- Publication type:
- Table of Contents
Familial Pancreatic Cancer.
- Published in:
- Oncology Research & Treatment, 2018, v. 41, n. 10, p. 611, doi. 10.1159/000493473
- By:
- Publication type:
- Article
Current Therapeutic Options for Pancreatic Ductal Adenocarcinoma.
- Published in:
- Oncology Research & Treatment, 2018, v. 41, n. 10, p. 590, doi. 10.1159/000493868
- By:
- Publication type:
- Article
Precursor Lesions of Pancreatic Cancer.
- Published in:
- Oncology Research & Treatment, 2018, v. 41, n. 10, p. 603, doi. 10.1159/000493554
- By:
- Publication type:
- Article
Novel Targets in Pancreatic Cancer Therapy - Current Status and Ongoing Translational Efforts.
- Published in:
- Oncology Research & Treatment, 2018, v. 41, n. 10, p. 596, doi. 10.1159/000493437
- By:
- Publication type:
- Article
Targeting Defects in the Cellular DNA Damage Response for the Treatment of Pancreatic Ductal Adenocarcinoma.
- Published in:
- Oncology Research & Treatment, 2018, v. 41, n. 10, p. 619, doi. 10.1159/000493401
- By:
- Publication type:
- Article
'Diseases Desperate Grown by Desperate Appliance Are Relieved, or Not at all' - Towards Finding a Cure for Pancreatic Cancer, Where Do We Stand Today?.
- Published in:
- Oncology Research & Treatment, 2018, v. 41, n. 10, p. 588, doi. 10.1159/000493023
- By:
- Publication type:
- Article
Successful Evidence-Based Treatment of Patients with Advanced Pancreatic Cancer in Community-Based Oncology Group Practices.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 12, p. 784, doi. 10.1159/000480016
- By:
- Publication type:
- Article
DRUG DELIVERY STRATEGIES FOR THE 21ST CENTURY.
- Published in:
- Biologist, 2018, v. 65, n. 4, p. 43
- By:
- Publication type:
- Article
Metabolomic evaluation of Mitomycin C and rapamycin in a personalized treatment of pancreatic cancer.
- Published in:
- Pharmacology Research & Perspectives, 2014, v. 2, n. 6, p. n/a, doi. 10.1002/prp2.67
- By:
- Publication type:
- Article
Radiofrequency treatment alters cancer cell phenotype.
- Published in:
- Scientific Reports, 2015, p. 12083, doi. 10.1038/srep12083
- By:
- Publication type:
- Article
Caveolin-1 is Associated with Tumor Progression and Confers a Multi-Modality Resistance Phenotype in Pancreatic Cancer.
- Published in:
- Scientific Reports, 2015, p. 10867, doi. 10.1038/srep10867
- By:
- Publication type:
- Article
Enriched Environment Inhibits Mouse Pancreatic Cancer Growth and Down-regulates the Expression of Mitochondria-related Genes in Cancer Cells.
- Published in:
- Scientific Reports, 2015, p. 7856, doi. 10.1038/srep07856
- By:
- Publication type:
- Article
Commonly Used Pancreatic Stellate Cell Cultures Differ Phenotypically and in Their Interactions with Pancreatic Cancer Cells.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 1, p. 23, doi. 10.3390/cells8010023
- By:
- Publication type:
- Article
Effect of the Natural Product Triptolide on Pancreatic Cancer: A Systematic Review of Preclinical Studies.
- Published in:
- Frontiers in Pharmacology, 2017, p. 1, doi. 10.3389/fphar.2017.00490
- By:
- Publication type:
- Article
Enhancing Drug Efficacy and Therapeutic Index through Cheminformatics-Based Selection of Small Molecule Binary Weapons That Improve Transporter-Mediated Targeting: A Cytotoxicity System Based on Gemcitabine.
- Published in:
- Frontiers in Pharmacology, 2017, v. 8, p. 1, doi. 10.3389/fphar.2017.00155
- By:
- Publication type:
- Article
Dipeptidyl-peptidase-4 inhibitors and pancreatic cancer: a cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2014, v. 16, n. 12, p. 1247, doi. 10.1111/dom.12379
- By:
- Publication type:
- Article
The glucagon-like peptide-1-based therapeutics exenatide and saxagliptin did not cause detrimental effects on the pancreas in mice, rats, dogs and monkeys.
- Published in:
- Diabetes, Obesity & Metabolism, 2014, v. 16, n. 10, p. 910, doi. 10.1111/dom.12294
- By:
- Publication type:
- Article
Activation of glucagon-like peptide-1 receptor inhibits tumourigenicity and metastasis of human pancreatic cancer cells via PI3K/Akt pathway.
- Published in:
- Diabetes, Obesity & Metabolism, 2014, v. 16, n. 9, p. 850, doi. 10.1111/dom.12291
- By:
- Publication type:
- Article
The Prevalence of Founder Mutations among Individuals from Families with Familial Pancreatic Cancer Syndrome.
- Published in:
- Cancer Research & Treatment, 2017, v. 49, n. 2, p. 430, doi. 10.4143/crt.2016.217
- By:
- Publication type:
- Article
Prognostic Factors for Risk Stratification of Patients with Recurrent or Metastatic Pancreatic Adenocarcinoma Who Were Treated with Gemcitabine-Based Chemotherapy.
- Published in:
- Cancer Research & Treatment, 2016, v. 48, n. 4, p. 1264, doi. 10.4143/crt.2015.250
- By:
- Publication type:
- Article
Concurrent Chemoradiotherapy Versus Chemotherapy Alone for Unresectable Locally Advanced Pancreatic Cancer: A Retrospective Cohort Study.
- Published in:
- Cancer Research & Treatment, 2016, v. 48, n. 3, p. 1045, doi. 10.4143/crt.2015.226
- By:
- Publication type:
- Article
The Impact of Diabetes Mellitus and Metformin Treatment on Survival of Patients with Advanced Pancreatic Cancer Undergoing Chemotherapy.
- Published in:
- Cancer Research & Treatment, 2016, v. 48, n. 1, p. 171, doi. 10.4143/crt.2014.292
- By:
- Publication type:
- Article